Advertisement

Vergleich oder Kombination von ß-BIockern und Kalziumantagonisten bei stabiler und instabiler Angina pectoris

  • M. C. M. Portegies
  • K. I. Lie

Zusammenfassung

Der vorliegende Beitrag gibt einen Überblick zum Thema Vergleich oder Kombination von β-Blockern und Kalziumantagonisten bei stabiler und instabiler Angina pectoris. Diskutiert werden Fragen wie Symptomatik, Belastungstoleranz, Ischämie unter Alltagsbelastung, Morbidität und Mortalität.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Selwyn AP, Yeung AC, Ryan TJ, Raby K, Barry J, Ganz P (1992) Pathophysiology of ischemia in patients with coronary artery disease. Prog Cardiovasc Dis 35: 27–39.PubMedCrossRefGoogle Scholar
  2. 2.
    Pepine CJ (1993) Betablockers or calcium antagonists in silent ischemia? Eur Heart J 14: F7–F14.Google Scholar
  3. 3.
    Portegies MCM, Gilst WH van, Lie KI. (1994) Treatment of myocardial ischemia with calcium antagonists High blood pressure 3 (Suppl. 1) 1–12.Google Scholar
  4. 4.
    Picca M, Azzollini F, Cereda A, Pelosi G (1989) Comparison of the antianginal efficacy of four calcium antagonists and propranolol in stable angina pectoris. Eur J Clin Pharmacol 37: 325–331.PubMedCrossRefGoogle Scholar
  5. 5.
    Opie LH (1994) Angina pectoris and calcium antagonists. In: LH Opie (ed) Myocardial pro-tection by calcium antagonists. Wiley-Liss, New York, pp 62–69.Google Scholar
  6. 6.
    Van Dijk RB, Lie KI, Crijns HJGM (1988) Diltiazem in comparison with metoprolol in stable angina pectoris. Eur Heart J 9: 1194–1199.PubMedGoogle Scholar
  7. 7.
    Findlay IN, MacLeod K, Gillen G et al. (1987) A double-blind placebo-controlled comparison of verapamil, atenolol, and their combination in patients with chronic stable angina pectoris. Br Heart J 57: 336–343.PubMedCrossRefGoogle Scholar
  8. 8.
    Shapiro W, Narahara KA, Kostis JB et al. (1989) Comparison of atenolol and nifedipine in chronic stable angina pectoris. Am J Cardiol 64: 186–190.PubMedCrossRefGoogle Scholar
  9. 9.
    Borzak S, Fenton R, Glasser S et al. for the Angina and Silent Ischemia Study Group (ASIS) (1993) Discordance between effects of anti-ischemic therapy on ambulatory ischemia, exercise performance and anginal symptoms in patients with stable angina pectoris. J Am Coll Cardiol 21: 1605–1611.CrossRefGoogle Scholar
  10. 10.
    Kostuk WJ, Pflugfelder O (1987) Comparative effects of calcium-entry blocking drugs, beta- blocking drugs, and their combination in patients with chronic stable angina. Circulation 75: V114–V121.PubMedGoogle Scholar
  11. 11.
    Brouwer J, Viersma JW, Van Veldhuisen DJ et al. (1995) Usefulness of heart rate variability in predicting drug efficacy (metoprolol vs. diltiazem) in patients with stable angina pectoris. Am J Cardiol 76: 759–763.PubMedCrossRefGoogle Scholar
  12. 12.
    Portegies MCM, Sijbring P, Gobel EJAM, Viersma JW, Lie KI (1994) Efficacy of metoprolol and diltiazem in treating silent myocardial ischemia. Am J Cardiol 74: 1095–1098.PubMedCrossRefGoogle Scholar
  13. 13.
    Arnim T von for the TIBBS Investigators (1995) Medical treatment to reduce total ischemic burden: Total Ischemic Burden Bisoprolol Study (TIBBS), a multicenter trial comparing biso- prolol and nifedipine. J Am Coll Cardiol 25: 231–238.CrossRefGoogle Scholar
  14. 14.
    Mulcahy D, Cunningham D, Crean P et al. (1988) Circadian variation of total ischemic burden and its alteration with anti-anginal agents. Lancet ii: 755–759.CrossRefGoogle Scholar
  15. 15.
    Theroux P, Baird M, Juneau M et al. (1991) Effect of diltiazem on symptomatic and asymptomatic episodes of ST segment depression occurring during daily life and during exercise. Circulation 84: 15–22.PubMedGoogle Scholar
  16. 16.
    Parmley WW, Nesto RW, Singh BN, Deanfield J, Gottlieb SO (1992) Attenuation of the circadian patterns of myocardial ischemia with nifedipine GITS in patients with chronic stable angina. J Am Coll Cardiol 19: 1380–1389.PubMedCrossRefGoogle Scholar
  17. 17.
    Rocco MB, Nabel EG, Campbell S, Goldman L (1988) Prognostic importance of myocardial ischemia detected by ambulatory monitoring in patients with coronary disease. Circulation 78: 877–884.PubMedCrossRefGoogle Scholar
  18. 18.
    Deedwania PC, Carbajal EV (1990) Silent ischemia during daily life is an independent predictor of mortality in stable angina. Circulation 81: 748–756.PubMedCrossRefGoogle Scholar
  19. 19.
    Pepine CJ, Cohn PF, Deedwania PC et al. (1994) Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST). Circulation 90: 762–768.PubMedGoogle Scholar
  20. 20.
    Dargie HJ, Fox KM (1996) Total Ischemic Burden European Trial (TIBET). Effects of ischemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina. Eur Heart J 17: 104–112.PubMedGoogle Scholar
  21. 21.
    Rehnqvist N, Hjemdahl P, Billing E et al. (1996) Effects of metoprolol vs. verapamil in patients with stable angina pectoris. The angina Prognosis Study in Stockholm (APSIS). Eur Heart J 17: 76–81.PubMedGoogle Scholar
  22. 22.
    Rogers W, Bourassa MG, Andrews TC et al. (1995) Asymptomatic Cardiac Ischemia Pilot (ACIP) Study: Outcome at 1 year for patients with asymptomatic cardiac ischemia randomized to medical therapy or revascularization. J Am Coll Cardiol 26: 594–605.PubMedCrossRefGoogle Scholar
  23. 23.
    Kostuk WJ, Pflugfelder P (1987) Comparative effects of calcium entry-blocking drugs, beta- blocking drugs, and their combination in patients with chronic stable angina. Circulation 75(suppl V): V-114–V-121.Google Scholar
  24. 24.
    El-Tamimi, Davies GJ, Kaski J-C et al. (1989) Effects of diltiazem alone or with isosorbidedi- nitrate or with atenolol both acutely and chronically for stable angina pectoris. Am J Cardiol 64: 717–724.PubMedCrossRefGoogle Scholar
  25. 25.
    Dargie HJ, Kynch PG, Krikler DM, Harrsi L, Krikler S (1981) Nifedipine and propranolol: a beneficial drug interaction. Am J Med 71: 676–682.PubMedCrossRefGoogle Scholar
  26. 26.
    Hill JA, Gonzalez JI, Kolb R, Pepine CJ (1991) Effects of atenolol alone, nifedipine alone and their combination on ambulant myocardial ischemia. Am J Cardiol 67: 671–675.PubMedCrossRefGoogle Scholar
  27. 27.
    Egstrup K (1988) Randomized double-blind comparison of metoprolol, nifedipine, and their combination in chronic stable angina: effects on total ischemic activity and heart rate at onset of ischemia. Am Heart J 116: 971–978.PubMedCrossRefGoogle Scholar
  28. 28.
    Savonitto S, Ardissino D, Egstrup K et al. (1996) Combination therapy with metoprolol and nifedipine versus monotherapy in patients with stable angina pectoris. Results of the Interna-tional Multicenter Angina Exercise (IMAGE) Study. J Am Coll Cardiol 27: 311–316.PubMedCrossRefGoogle Scholar
  29. 29.
    Akhras F, Jackson G (1991) Efficacy of nifedipine and isosorbide mononitrate in combination with atenolol in stable angina pectoris. Lancet 338: 1036–1039.PubMedCrossRefGoogle Scholar
  30. 30.
    Dunselman PHJM, Liem AH for the Working Group on Cardiovascular Research the Netherlands (1996) Felodipine, metoprolol and their combination for the treatment of stable angina pectoris. Cardiology 3: 206.Google Scholar
  31. 31.
    Vries RJ de, Dunselman PHJM, Veldhuisen DJ van, Heuvel AF van den, Wielenga RP, Lie KI (1994) Comparison between felodipine. and isosorbide mononitrate as adjunct to beta- blockade in patients >65 years of age with angina pectoris. Am J Cardiol 74: 1201–1206.PubMedCrossRefGoogle Scholar
  32. 32.
    Egstrup K, Andersen, PE (1993) Transient myocardial ischemia during nifedipine therapy in stable angina pectoris and its relation to coronary collateral flow. Am J Cardiol 71: 177–183.PubMedCrossRefGoogle Scholar
  33. 33.
    Maseri A (1995) Regulation of coronary vasomotore tone. In: Maseri A (ed) Ischemic heart disease. Churchill, Livingstone, New York p 9–105, chapter 5.Google Scholar
  34. 34.
    Report of the Holland Interuniversity Nifedipine/Metoprolol Trial (HINT) Research Group. (1986) Early treatment of unstable angina in the coronary care unit: a randomised, double blind, placebo controlled comparison of recurrent ischemia in patients treated with nifedipine or metoprolol or both. Br Heart J 56: 400–413.CrossRefGoogle Scholar
  35. 35.
    Muller JE, Morrison J, Stone P et al. (1984) Nifedipine therapy for patients with threatened and acute myocardial infarction: a randomized double blind placebo controlled comparison. Circulation 69: 740–747.PubMedCrossRefGoogle Scholar
  36. 36.
    Gobel EJAM, Hautvast RWM, Gilst WH van et al. (1995) Randomized double-blind trial of diltiazem versus glyceryl trinitrate for unstable angina pectoris. Lancet 346: 1653–1657.PubMedCrossRefGoogle Scholar
  37. 37.
    Gerstenblith G, Ouyang P, Aschuff SC et al. Nifedipine in unstable angina. A double-blind randomised trial. N Engl J Med 306: 885–889.Google Scholar
  38. 38.
    Muller JE, Turi ZG, Pearle DL et al. (1984) Nifedipine and conventional therapy for unstable angina pectoris: a randomized, double-blind comparison. Circulation 69: 728–739.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1997

Authors and Affiliations

  • M. C. M. Portegies
  • K. I. Lie

There are no affiliations available

Personalised recommendations